On the other hand, Chen et al focused on understanding trastuzumab resistance in gastric cancer, identifying GNGT1, KRT7, KRT16, SOX9, and TIMP1 as promising diagnostic biomarkers for gastric cancer. This evidence concerns the gene TIMP1 and gastric cancer.